Dehydrocurvularin is a potent antineoplastic agent irreversibly blocking ATP-citrate lyase: evidence from chemoproteomics

被引:25
作者
Deng, Zhangshuang [1 ,2 ,3 ]
Wong, Nai-Kei [4 ]
Guo, Zhiyong [2 ]
Zou, Kun [2 ]
Xiao, Youli [5 ]
Zhou, Yiqing [1 ,5 ]
机构
[1] Changshu Inst Technol, Sch Biotechnol & Food Engn, Changshu 215500, Jiangsu, Peoples R China
[2] China Three Gorges Univ, Coll Biol & Pharmaceut Sci, Hubei Key Lab Nat Prod Res & Dev, Yichang 443002, Peoples R China
[3] China Three Gorges Univ, Key Lab Three Gorges Reg Plant Genet & Germplasm, Yichang 443002, Peoples R China
[4] Southern Univ Sci & Technol, Hosp 2, Shenzhen Peoples Hosp 3, Dept Infect Dis, Shenzhen 518112, Peoples R China
[5] Chinese Acad Sci, CAS Ctr Excellence Mol Plant Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China
关键词
INHIBITION; TARGETS; GLUCOSE;
D O I
10.1039/c9cc00256a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Natural-product macrolide 10,11-dehydrocurvularin (DCV) was revealed to be a potent irreversible inhibitor of ATP-citrate lyase (ACLY) via classical chemoproteomic profiling, which mechanistically illuminates the anti-cancer mode of action of DCV and its analogues.
引用
收藏
页码:4194 / 4197
页数:4
相关论文
共 20 条
[1]   De nova lipogenesis in health and disease [J].
Ameer, Fatima ;
Scandiuzzi, Lisa ;
Hasnain, Shahida ;
Kalbacher, Hubert ;
Zaidi, Nousheen .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (07) :895-902
[2]   ATP-citrate lyase: A mini-review [J].
Chypre, Melanie ;
Zaidi, Nousheen ;
Smans, Karine .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 422 (01) :1-4
[3]  
Deng ZS, 2015, NAT PROD COMMUN, V10, P1277
[4]   Electrophilic natural products and their biological targets [J].
Gersch, Malte ;
Kreuzer, Johannes ;
Sieber, Stephan A. .
NATURAL PRODUCT REPORTS, 2012, 29 (06) :659-682
[5]   ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism [J].
Granchi, Carlotta .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 :1276-1291
[6]   Fungal metabolites: structural diversity as incentive for anticancer drug development [J].
Greve, Hendrik ;
Mohamed, Ietidal E. ;
Pontius, Alexander ;
Kehraus, Stefan ;
Gross, Harald ;
Koenig, Gabriele M. .
PHYTOCHEMISTRY REVIEWS, 2010, 9 (04) :537-545
[7]   ATP citrate lyase inhibition can suppress tumor cell growth [J].
Hatzivassiliou, G ;
Zhao, FP ;
Bauer, DE ;
Andreadis, C ;
Shaw, AN ;
Dhanak, D ;
Hingorani, SR ;
Tuveson, DA ;
Thompson, CB .
CANCER CELL, 2005, 8 (04) :311-321
[8]   ATP-citrate lyase is essential for macrophage inflammatory response [J].
Infantino, Vittoria ;
Iacobazzi, Vito ;
Palmieri, Ferdinando ;
Menga, Alessio .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 440 (01) :105-111
[9]   Radicicol binds and inhibits mammalian ATP citrate lyase [J].
Ki, SW ;
Ishigami, K ;
Kitahara, T ;
Kasahara, K ;
Yoshida, M ;
Horinouchi, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) :39231-39236
[10]   2-Hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors [J].
Li, James J. ;
Wang, Haixia ;
Tino, Joseph A. ;
Robl, Jeffrey A. ;
Herpin, Timothy F. ;
Lawrence, R. Michael ;
Biller, Scott ;
Jamil, Haris ;
Ponticiello, Randy ;
Chen, Luping ;
Chu, Ching-hsuen ;
Flynn, Neil ;
Cheng, Dong ;
Zhao, Rulin ;
Chen, Bangchi ;
Schnur, Dora ;
Obermeier, Mary T. ;
Sasseville, Vito ;
Padmanabha, Ramesh ;
Pike, Kristen ;
Harrity, Thomas .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (11) :3208-3211